HL7 Interface Testing Checklist
July 8, 2014
Over the past few weeks, we’ve reviewed multiple HL7 testing topics. So you know how critical it is to test interfaces during interface configuration, the
Over the past few weeks, we’ve reviewed multiple HL7 testing topics. So you know how critical it is to test interfaces during interface configuration, the
Tip 16 in the Interoperability Tip Series The past few tips have covered HL7 testing and test automation. This one covers what you should do
This release is focused on test automation within the Caristix platform. We’ve developed significant new features to accelerate test creation and test execution. This will
Tip 15 in the Interoperability Tip Series Once you’ve developed a test plan and test scenarios, you need to configure your interface in a test
We get this question a lot. Over the past few years, we’ve come up with a few answers. Let’s bring this full circle into 3
Tip 14 in the Interoperability Tip Series In last week’s tip, we talked about capturing workflows. Here’s why. Before you can conduct any interface testing,
Testing and validation are important tasks, as we explained in the Interoperability Tip Series and the HL7 Survival Guide. Shouldn’t interfacing be easy by now?
Tip 13 in the Interoperability Tip Series Last week in Tip 12, we covered when, why, and what to test when you’re working with interfaces.
Tip 12 in the Interoperability Tip Series In tips from the past few weeks, we covered two requirements-related artifacts analysts must create: 1) profiles or
9 Diagnostic Questions: Interfacing Management Maturity Model Last week, we introduced a maturity model for interfacing management. We explained how organizations progress through 3 distinct
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.